BIOVENTUS INC. - CLASS A COMMON STOCK
6.7900
16-五月-25 16:45:00
15 分钟延时
股票
+0.2500
+3.82%
今日范围
6.5100 - 6.9600
ISIN
N/A
来源
NASDAQ
-
Bioventus Reports First Quarter Financial Results
06 5月 2025 07:30:00 条件 Nasdaq GlobeNewswire
-
Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025
28 4月 2025 08:00:00 条件 Nasdaq GlobeNewswire
-
Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results
11 3月 2025 07:30:01 条件 Nasdaq GlobeNewswire
-
Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025
28 2月 2025 07:30:00 条件 Nasdaq GlobeNewswire
-
Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference
07 1月 2025 08:00:01 条件 Nasdaq GlobeNewswire
-
Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
02 1月 2025 08:00:00 条件 Nasdaq GlobeNewswire
-
Bioventus Reports Third Quarter Financial Results
05 11月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024
29 10月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
01 10月 2024 09:00:01 条件 Nasdaq GlobeNewswire
-
Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference
07 8月 2024 16:15:00 条件 Nasdaq GlobeNewswire
-
Bioventus Reports Second Quarter Financial Results
06 8月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024
30 7月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Bioventus Reports First Quarter Financial Results
07 5月 2024 07:00:01 条件 Nasdaq GlobeNewswire
-
Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
29 4月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
12 3月 2024 07:30:01 条件 Nasdaq GlobeNewswire
-
Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024
04 3月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
18 1月 2024 16:15:00 条件 Nasdaq GlobeNewswire
-
Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole
12 1月 2024 16:15:00 条件 Nasdaq GlobeNewswire
-
Bioventus Names Robert Claypoole as President and Chief Executive Officer
19 12月 2023 16:30:00 条件 Nasdaq GlobeNewswire
-
06 12月 2023 08:00:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >